© 2022 Global Market Insights Inc. All Rights Reserved www.gminsights.com
Vitreoretinal Surgery Devices Market by Type, Application,
Element - Global Trends and Forecast to 2028
Global Market Insights recently introduced report on global Vitreoretinal Surgery Devices
Market report is an in-depth study providing complete analysis of the industry for the period
2022 to 2028. It provides complete overview of the industry considering all the major industry
trends, market dynamics and competitive scenario.
Get sample copy of this research report @ https://www.gminsights.com/request-
sample/detail/3417
The vitreoretinal surgery devices market is expected to grow substantially by 2028 owing to
technological advancements in retinal surgery. In addition, surging availability of novel
products that make surgeries simpler and more convenient is likely to further support market
growth through the forecast timeline.
Recently, industry players have been adopting lucrative strategies to gain a competitive edge
in the business, which has enhanced market dynamics. For instance, in January 2021, DORC,
a Dutch ophthalmic research center, reported that it had received approval from Health
Canada for the application of TissueBlue 0.025% and will be made available through
INNOVAMED, its local distributor partner. TissueBlue would serve as a safe and effective
alternative to ICG and other compounded or off-label staining agents formerly used in
Canada.
Moreover, during the COVID-19 pandemic, ophthalmologists needed to limit the risk of
exposure to COVID-19 during hospital visits and stays without compromising the efficacy of
surgical processes, which restricted the number of surgeries performed, thereby hampering
the growth of the market. However, widespread vaccination drives all over the world and
increased focus on economic recovery have prompted patients to opt for surgeries, which has
been favorable for market growth.
The vitreoretinal surgery devices market has been segmented o